Union Bancaire Privee’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.2M Sell
370,591
-5,393
-1% -$1.16M 0.94% 21
2026
Q1
$73M Sell
375,984
-67,022
-15% -$14.9M 1.01% 17
2025
Q4
$95.3M Buy
443,006
+46,028
+12% +$10.5M 1.13% 13
2025
Q3
$82M Buy
396,978
+61,740
+18% +$12.6M 1.17% 18
2025
Q2
$59.7M Buy
335,238
+334,490
+44,718% +$62.2M 0.87% 29
2025
Q1
$148K Hold
748
﹤0.01% 390
2024
Q4
$127K Buy
+748
New +$138K ﹤0.01% 437

Other funds holding ABBV

Union Bancaire Privee's ABBV Position: Q2 2026 in Review

Union Bancaire Privee reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $1.16M and leaving 370,591 shares worth $86.2M. The position accounts for 0.94% of the portfolio, ranked #21.

Union Bancaire Privee first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $95.3M in Q4 2025. 1,906 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Union Bancaire Privee held 370,591 shares of AbbVie worth $86.2M as of Q2 2026.
  • Union Bancaire Privee sold 5,393 AbbVie shares in Q2 2026, an estimated $1.16M.
  • AbbVie made up 0.94% of Union Bancaire Privee's portfolio in Q2 2026, its #21 holding.
  • Union Bancaire Privee first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Union Bancaire Privee's AbbVie position peaked at $95.3M in Q4 2025.
  • 1,906 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.